Experimental Moderna flu shot more effective than approved vaccine, company says

Moderna Inc. said Monday its experimental flu changeable showed affirmative results successful a late-stage trial.   In a Phase 3 study, the company’s mRNA-1010 flu vaccine’s efficacy was astir 27 percent higher for adults 50 and older than a presently disposable shot. The changeable besides showed beardown efficacy against each of the large influenza strains…